HomeCompareMDIBF vs CHD

MDIBF vs CHD: Dividend Comparison 2026

MDIBF yields 5.66% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDIBF wins by $12508.94M in total portfolio value
10 years
MDIBF
MDIBF
● Live price
5.66%
Share price
$23.60
Annual div
$1.34
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12508.97M
Annual income
$12,098,223,368.33
Full MDIBF calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — MDIBF vs CHD

📍 MDIBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDIBFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDIBF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDIBF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDIBF
Annual income on $10K today (after 15% tax)
$480.96/yr
After 10yr DRIP, annual income (after tax)
$10,283,489,863.08/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, MDIBF beats the other by $10,283,488,764.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDIBF + CHD for your $10,000?

MDIBF: 50%CHD: 50%
100% CHD50/50100% MDIBF
Portfolio after 10yr
$6254.50M
Annual income
$6,049,112,330.41/yr
Blended yield
96.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

MDIBF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.1
Piotroski
3/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDIBF buys
0
CHD buys
0
No recent congressional trades found for MDIBF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDIBFCHD
Forward yield5.66%1.27%
Annual dividend / share$1.34$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%23.1%
Portfolio after 10y$12508.97M$26.4K
Annual income after 10y$12,098,223,368.33$1,292.51
Total dividends collected$12480.40M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: MDIBF vs CHD ($10,000, DRIP)

YearMDIBF PortfolioMDIBF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$11,832$1,131.66$10,856$156.32+$976.00MDIBF
2$15,163$2,502.70$11,811$195.24+$3.4KMDIBF
3$22,219$5,994.91$12,883$244.38+$9.3KMDIBF
4$40,194$16,420.19$14,091$306.64+$26.1KMDIBF
5$98,530$55,522.31$15,463$385.88+$83.1KMDIBF
6$359,828$254,400.66$17,033$487.17+$342.8KMDIBF
7$2,121,576$1,736,559.50$18,843$617.36+$2.10MMDIBF
8$21,408,208$19,138,122.60$20,947$785.72+$21.39MMDIBF
9$383,873,677$360,966,894.01$23,419$1,004.91+$383.85MMDIBF
10$12,508,968,203$12,098,223,368.33$26,350$1,292.51+$12508.94MMDIBF

MDIBF vs CHD: Complete Analysis 2026

MDIBFStock

Mediobanca Banca di Credito Finanziario S.p.A., together with its subsidiaries, provides various banking products and services in Italy and internationally. The company operates through Wealth Management, Consumer Banking, Corporate and Investment Banking, Principal Investing, and Holding Functions segments. The Wealth Management segment offers asset management and other services to private clients, and affluent and premier customers. The Consumer Banking segment provides a range of consumer credit products comprising personal loans and salary-backed finances; personal loan services for cars and motorcycles, consumer electronics, furniture, and travel; payment services that include credit cards and salary-backed loans; insurance products; and instalment payment solutions for online purchases. The Corporate and Investment Banking segment offers wholesale banking products and services, including lending, advisory, capital market, and proprietary trading services; and specialty finance services, such as factoring and credit management, as well as non-performing loans portfolio acquisitions and management. The Principal Investing segment engages in the equity investment and holding activities. The Holding Functions segment engages in treasury, and asset and liability management operations. The company was founded in 1946 and is headquartered in Milan, Italy.

Full MDIBF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this MDIBF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDIBF vs SCHDMDIBF vs JEPIMDIBF vs OMDIBF vs KOMDIBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.